CME: Examining Emergency Department Returns for Kidney Stones

CME: Examining Emergency Department Returns for Kidney Stones
Author Information (click to view)

Charles D. Scales, Jr., MD, MSHS

Assistant Professor of Surgery, Division of Urologic Surgery
Assistant Residency Program Director for Quality Improvement & Patient Safety
Duke University Medical Center

Charles D. Scales Jr., MD, MSHS, has indicated to Physician’s Weekly that he has or has had no financial interests to report.

Figure 1 (click to view)
Target Audience (click to view)

This activity is designed to meet the needs of physicians.

Learning Objectives(click to view)

Upon completion of the educational activity, participants should be able to:

 

  • Characterize the frequency of emergency department revisits among patients with kidney stones.
  • Discuss potentially independent links between emergency department revisits and clinical and non-clinical factors.

Method of Participation(click to view)

Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation.  A statement of credit will be available upon completion of an online evaluation/claimed credit form at http://akhcme.com/akhcme/lessons/46.  You must participate in the entire activity to receive credit.  If you have questions about this CME/CE activity, please contact AKH Inc. at dcotterman@akhcme.com.

Credit Available(click to view)

AKH

CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

 

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support(click to view)

There is no commercial support for this activity.

Disclosures(click to view)

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use & Investigational Product(click to view)

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer(click to view)

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Faculty & Credentials(click to view)

Keith D’Oria – Editorial Director
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
Charles D. Scales, Jr., MD, MSHS
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH and PHYSICIAN WEEKLY’S STAFF/REVIEWERS

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.

AKH planners and reviewers have no relevant financial relationships to disclose.

+


Charles D. Scales, Jr., MD, MSHS (click to view)

Charles D. Scales, Jr., MD, MSHS

Assistant Professor of Surgery, Division of Urologic Surgery
Assistant Residency Program Director for Quality Improvement & Patient Safety
Duke University Medical Center

Charles D. Scales Jr., MD, MSHS, has indicated to Physician’s Weekly that he has or has had no financial interests to report.

+
Many patients requiring emergent care for kidney stones appear to be at risk for revisiting the ED for the condition. Efforts are needed to manage preventable causes of these revisits. Increasing access to urologic care and improving processes of care may lower the risk of repeat emergent encounters.

According to published estimates, kidney stones afflict nearly one in 11 people in the United States at least once in their lifetime and cause excruciating pain, especially when stones are passed. Some patients with kidney stones are able to pass their stones while others require procedural interventions. “Studies have shown that the rate of ED visits for kidney stones has nearly doubled over the past 15 years,” says Charles D. Scales, Jr., MD, MSHS. “More than 90% of patients who are evaluated in EDs for kidney stones are released after treatment, but little is known about what happens to these patients after they’re discharged.” He adds that preventing repeat ED visits for kidney stones is important because they contribute to inefficient and potentially costly care.

 

Characterizing the Problem

In a study published in Academic Emergency Medicine, Dr. Scales and colleagues sought to characterize the frequency of ED revisits in a large, all-payer cohort. The investigators also aimed to identify potentially independent links between ED revisits and clinical and non-clinical factors. “Overall, our goal was to identify potential targets for improving emergency care for patients with kidney stones,” Dr. Scales says. The retrospective cohort study analyzed all patients in California who were initially treated and released from EDs for kidney stones between February 2008 and November 2009.

Of the more than 128,000 kidney stone patients involved in the study who were discharged from emergent care, 11% had at least one additional emergent visit within the next month to manage additional symptoms. “Among these patients, about one-third required hospitalization or an urgent temporizing procedure at their second visit,” Dr. Scales says.

Several factors were identified as increasing the likelihood of ED revisits for patients with kidney stones. Such revisits were more likely among younger and white, non-Hispanic people. The odds of an ED revisit were 52% higher for Medicaid beneficiaries than for those with private insurance. A higher per-capita density of urologists was also linked to lower odds of an ED revisit, but no associations were observed when comparing weekday and weekend encounters.

 

Revisit Outcomes

The study also found that more than 13,000 patients experienced ED revisits, and 29% of these individuals were either admitted to the hospital or underwent an urgent procedure as a result of their revisit. These outcomes varied by clinical and non-clinical factors. The need for hospitalization or urgent procedures was 3.9 times more likely for patients aged 75 and older when compared with younger individuals. Women were nearly twice as likely as men to be admitted or undergo urgent procedures. Patients who revisited the ED and lived in areas with the highest per-capita supply of urologists were most likely to be hospitalized or undergo a procedure.

 

The Role of Diagnostics

Several diagnostic tests are recommended for use when evaluating patients with suspected kidney stones, including imaging, complete blood counts, assessment of renal function, and urinalysis. The study, however, found that only performance of a blood count was associated with the probability of an ED revisit (Table). “Patients who had white blood cell counts performed at their initial visit had about a 14% lower risk of revisiting the ED when compared with those who didn’t receive this testing,” says Dr. Scales. Conversely, the authors found that urinalysis, imaging, and assessment of renal function were not associated with increased odds of ED revisits.

 

Potential Solutions

Findings of the study suggest that repeat ED care is an important problem and a potential quality-of-care marker for patients with kidney stones. According to Dr. Scales, the prevalence of kidney stones is likely to increase as obesity rates escalate from Americans practicing poor dietary and lifestyle health practices. “We may be able to reduce costs and improve outcomes by finding ways to optimize care,” he says. “Efforts are needed to improve the quality of care at first ED visit for kidney stones as well as at revisits to the ED.”

Dr. Scales adds that increasing access to specialized treatment from urologists might be able to prevent a return ED visits. “If we better coordinate care for kidney stones with primary care and urology, we may be able to improve outcomes for patients and reduce their need to use the ED for care,” he says. “More research is needed to explore this potential solution, but it’s clear from our study that we should be motivated to identify preventable causes of ED revisits for kidney stones. Once identified, we should then design interventions that are aimed at reducing the risk of requiring repeat care.”

Readings & Resources (click to view)

Scales Jr CD, Lin L, Saigal CS, the NIDDK Urologic Diseases in America Project. Emergency department revisits for patients with kidney stones in California. Acad Emerg Med. 2015;22:468-474. Available at: http://onlinelibrary.wiley.com/doi/10.1111/acem.12632/abstract.

Meltzer AC, Pines JM. What big data can and cannot tell us about emergency department quality for urolithiasis. Acad Emerg Med. 2015;22:481-482.

Foster G, Stocks C, Borofsky MS. Emergency department visits and hospital admissions for kidney stone disease, 2009: statistical brief #139. 2012. Rockville, MD. Available at: http://www.ncbi.nlm.nih.gov/books/NBK100827/.

Fwu CW, Eggers PW, Kimmel PL, Kusek JW, Kirkali Z. Emergency department visits, use of imaging and drugs for urolithiasis have increased in the United States. Kidney Int. 2013;83:479-486. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587650/.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 × 4 =